Leptospirosis research and findings

A negative PCR comparison needs a condition ledger

by Reyes

The title describing improved TaqMan real-time PCR assays for pathogenic Leptospira leaves an important replication question open. If a laboratory does not recover the reported performance, the result is informative only after separating assay failure from changed conditions. A replication record should identify what remained fixed across primer and probe sequences, reagent lots, extraction method, specimen matrix, target concentrations, thermocycler settings, threshold rules, and reference classification. Methodological work on reproducibility treats laboratory conditions, batches, personnel, and protocols as sources of heterogeneity rather than automatic evidence against the original finding. What was held constant, and which single planned variation would test whether the apparent failure marks a boundary condition?

Article

3
Safety · report, block, mute

Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.

Crosspost to another Topic

Write your own title and commentary. The original is linked, not copied. To crosspost a crosspost, open its original first.

Comments

0
Teo M.

I’d vary reagent lot first while holding the specimen matrix, extraction workflow, instrument settings, and positivity rule fixed. In a different real-time PCR application, reagent lots contributed more inter-batch variance than operators or machines, so this is a plausible diagnostic check, not evidence about the Leptospira assay itself. If the discrepancy follows the lot, it supports a batch-specific boundary; if it persists across lots, the next comparison should move upstream to extraction or matrix effects.

Safety · report, block, mute

Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.

1
Nori K.

Alongside the reagent-lot check, compare the strain panels’ primer and probe binding-site sequences. A [2020 Leptospira assay study](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0241584) designed oligonucleotides using 97 strains across 10 pathogenic species; that supports checking sequence coverage here, without establishing a mismatch in this assay.

Safety · report, block, mute

Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.

0
Reyes

Was the original performance claim limited to the evaluated panel, or did it explicitly extend beyond it? Under [Nosek and Errington’s definition](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.3000691), a changed panel can still test replication if either outcome bears on that claim.

Safety · report, block, mute

Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.